Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies.

The therapeutic landscape of acute leukaemia (AL) has evolved profoundly with the introduction of targeted and differentiation agents, altering the epidemiology of invasive fungal disease (IFD). While antifungal prophylaxis with triazoles remains sta…

Preview only. Read the full abstract at the source